TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3175579

Group type: EXPERIMENTAL
Intervention: Metronidazole (1 g suppositories)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Ornidazole (500 mg iv or 500 mg suppositories)
Number of subjects: 187
Study: 1061225

Group type: EXPERIMENTAL
Intervention: Isokinetic bench press at 1.5 sec speed
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Isokinetic bench press at 2.0 sec speed
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Isokinetic bench press at 3.5 sec speed
Number of subjects: 11
Study: 31516116

Group type: EXPERIMENTAL
Intervention: Malaria infection
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Frequent use of bed nets
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Not always using latrines and eating raw uncooked food
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Malaria and STH infections
Number of subjects: 445
Study: 27059529

Group type: EXPERIMENTAL
Intervention: Insulin degludec/insulin aspart (IDegAsp)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Biphasic insulin aspart 30 (BIAsp 30)
Number of subjects: 178
Study: 26608441

Group type: EXPERIMENTAL
Intervention: Improving sleep quality activities (4 sessions of 2 hours each)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Regular greeting calls (Control)
Number of subjects: 59
Study: 23193010

Group type: EXPERIMENTAL
Intervention: Resting metabolic rate (RMR)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Change in resting metabolic rate (RMR)
Number of subjects: 41
Study: 21757372

Group type: EXPERIMENTAL
Intervention: Primary PTA
Number of subjects: 58

Group type: COMPARATOR
Intervention: SilverHawk atherectomy
Number of subjects: 58
Study: 19422357

Group type: EXPERIMENTAL
Intervention: Acid+capsaicin (200 ml solution: 180 ml HCL 0.1 M and 2 mg capsaicin in 20 ml solvent)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 15
Study: 17066105

Group type: EXPERIMENTAL
Intervention: 25 G spinal needle
Number of subjects: 100

Group type: COMPARATOR
Intervention: 26 G spinal needle
Number of subjects: 100
Study: 15298635

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 2645

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 2645

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg
Number of subjects: 2645
Study: 12577392

Group type: EXPERIMENTAL
Intervention: Shenmai injection (SMI) plus thrombolytic treatment
Number of subjects: 537

Group type: COMPARATOR
Intervention: Thrombolytic treatment only (Control)
Number of subjects: 537
Study: 9435936

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CF) 500 mg orally twice daily
Number of subjects: 72

Group type: COMPARATOR
Intervention: Ceftazidime (CT) 1 g intravenously twice daily
Number of subjects: 72
Study: 29239627

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Object-Relational Psychotherapy (ORP)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 106
Study: 27288987

Group type: EXPERIMENTAL
Intervention: Robotic-assisted laparoscopic surgery
Number of subjects: 101

Group type: COMPARATOR
Intervention: Traditional laparoscopic surgery
Number of subjects: 101
Study: 25037579

Group type: EXPERIMENTAL
Intervention: Responsive parenting intervention
Number of subjects: 316

Group type: COMPARATOR
Intervention: Home safety control
Number of subjects: 316
Study: 22699288

Group type: EXPERIMENTAL
Intervention: 0.5 units/kg/day insulin glargine and glulisine
Number of subjects: 107

Group type: COMPARATOR
Intervention: 0.25 units/kg/day insulin glargine and glulisine
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both dosing groups (0.5 and 0.25 units/kg/day)
Number of subjects: 107
Study: 19528133

Group type: EXPERIMENTAL
Intervention: Adjudicated outcomes
Number of subjects: 95038

Group type: COMPARATOR
Intervention: Reported outcomes
Number of subjects: 95038
Study: 16255837

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (clobetasol propionate 0.05%, betamethasone valerate 0.1%, clobetasone butyrate 0.05%)
Number of subjects: 19
Study: 14733854

Group type: EXPERIMENTAL
Intervention: Consulting of internal medicine (CIM) in primary care
Number of subjects: 2167

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 2167
Study: 11552710

Group type: EXPERIMENTAL
Intervention: Supplemental selenium
Number of subjects: 32400

Group type: EXPERIMENTAL
Intervention: Supplemental vitamin E
Number of subjects: 32400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32400
Study: 9589312

Group type: EXPERIMENTAL
Intervention: Patients with eating disorders (specific types not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-patients
Number of subjects: 0
Study: 8175215

Group type: EXPERIMENTAL
Intervention: Trefoil/Bifoil balloon catheter (n = 100, Group 1)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Inoue balloon catheter (n = 50, Group 2)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Inoue balloon technique
Number of subjects: 150
Study: 3168936

Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g QID before meals)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (identical-looking)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sucralfate (for gastric variceal ulcers)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (for gastric variceal ulcers)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ulcer size influence
Number of subjects: 45
Study: 31639790

Group type: EXPERIMENTAL
Intervention: Nicorandil (10 mg, t.i.d., starting 2 days before and continuing for 2 days after the procedure)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control (standard hydration treatment only)
Number of subjects: 252
Study: 25111433

Group type: EXPERIMENTAL
Intervention: Behavior therapy (behavior activation and problem-solving therapy)
Number of subjects: 80
Study: 23399554

Group type: EXPERIMENTAL
Intervention: Elemental diet
Number of subjects: 127

Group type: COMPARATOR
Intervention: Standard liquid diet
Number of subjects: 127
Study: 21654719

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (tri-weekly for 6 weeks)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sleep hygiene education (control group)
Number of subjects: 72
Study: 18475154

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) treatment
Number of subjects: 33

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 33
Study: 17089507

Group type: EXPERIMENTAL
Intervention: SMA CPB circuits
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard CPB circuits
Number of subjects: 28
Study: 15689052

Group type: EXPERIMENTAL
Intervention: D‐003 (20 mg/day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 11237927

Group type: EXPERIMENTAL
Intervention: Diet plus exercise (DE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diet (D)
Number of subjects: 40
Study: 9237088

Group type: EXPERIMENTAL
Intervention: Smoking with a distractor
Number of subjects: 124

Group type: COMPARATOR
Intervention: Smoking without a distractor
Number of subjects: 124

Group type: COMPARATOR
Intervention: Not smoking with a distractor
Number of subjects: 124

Group type: COMPARATOR
Intervention: Not smoking without a distractor
Number of subjects: 124
Study: 8481017

Group type: EXPERIMENTAL
Intervention: Ketotifen (2 to 4 mg per day)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 3115210

Group type: EXPERIMENTAL
Intervention: Ibuprofen (600 mg four times a day)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sulindac (200 mg twice a day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 29685459

Group type: EXPERIMENTAL
Intervention: Educational leaflet intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (no educational leaflet)
Number of subjects: 400
Study: 28845007

Group type: EXPERIMENTAL
Intervention: Foley catheter for nephrostomy tube (research group)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Normal nephrostomy tube (control group)
Number of subjects: 137
Study: 25181557

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 69

Group type: COMPARATOR
Intervention: Droperidol
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 69
Study: 23784369

Group type: EXPERIMENTAL
Intervention: Umeclidinium (10-350 μg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Umeclidinium (100 μg and above)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Tiotropium bromide (18 μg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 21757893

Group type: EXPERIMENTAL
Intervention: Marine omega-3 fatty acids (2,080 mg daily for 10 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 19452380

Group type: EXPERIMENTAL
Intervention: Aripiprazole titrated-dose (starting dose 5 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aripiprazole fixed-dose (dose 15 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aripiprazole titrated-dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aripiprazole fixed-dose
Number of subjects: 0
Study: 16422995

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg i.v.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 15149875

Group type: EXPERIMENTAL
Intervention: Plant stanol (STA)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Plant sterol (STE)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Intralipid
Number of subjects: 5
Study: 11736751

Group type: EXPERIMENTAL
Intervention: Plasmapheresis (10 days)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 4
Study: 9459029

Group type: EXPERIMENTAL
Intervention: Computed lateral cephalometry (30% reduced radiation, 70 kV, 15 mA, 0.35 s)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional lateral cephalometry (70 kV, 15 mA, 0.5 s)
Number of subjects: 20
Study: 8204472

Group type: EXPERIMENTAL
Intervention: Cyclosporin (5 mg/kg daily for 6 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 46
Study: 3284632

Group type: COMPARATOR
Intervention: Doxepin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marital therapy designed to enhance intimacy through self-disclosure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30797638

Group type: EXPERIMENTAL
Intervention: qHPV vaccine
Number of subjects: 1124

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1124
Study: 29184167

Group type: EXPERIMENTAL
Intervention: Nebivolol (NEB) 5/10 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Atenolol (ATE) 25/50 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 60
Study: 25403327

Group type: EXPERIMENTAL
Intervention: Rapeseed/canola oil (RA) supplementation (50 g daily for 4 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olive oil (OL) supplementation (50 g daily for 4 weeks)
Number of subjects: 0
Study: 24779956

Group type: EXPERIMENTAL
Intervention: Aerobic Training Group (ATG, n=19)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Combined Aerobic and Resistance Training Group (CTG, n=20)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control Group (n=20)
Number of subjects: 59
Study: 22591446

Group type: EXPERIMENTAL
Intervention: Motor physical therapy combined with neuromuscular electrical stimulation (NMES) on the tibialis anterior
Number of subjects: 0

Group type: COMPARATOR
Intervention: Motor physical therapy alone
Number of subjects: 0
Study: 18946808

Group type: EXPERIMENTAL
Intervention: Functional foot orthoses (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unshaped material (n=20)
Number of subjects: 40
Study: 17559750

Group type: EXPERIMENTAL
Intervention: Extended-release niacin (NIASPAN) 1 g (N1)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Extended-release niacin (NIASPAN) 2 g (N2)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 15252223

Group type: EXPERIMENTAL
Intervention: Methadone maintenance therapy at a dosage of 80-100 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methadone maintenance therapy at a dosage lower than 40 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methadone maintenance therapy with treatment duration of 90 days or less
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ancillary services provided at the beginning of methadone maintenance program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Programs involving more participants
Number of subjects: 0
Study: 12414201

Group type: EXPERIMENTAL
Intervention: Anterior-posterior electrode position
Number of subjects: 108

Group type: COMPARATOR
Intervention: Anterior-lateral electrode position
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Cross-over from anterior-lateral to anterior-posterior
Number of subjects: 108

Group type: COMPARATOR
Intervention: Cross-over from anterior-posterior to anterior-lateral
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Overall success after cross-over
Number of subjects: 108
Study: 9649694

Group type: EXPERIMENTAL
Intervention: TCR Vbeta 2
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: TCR Vbeta 2 and 17
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: TCR Vbeta 2, 6, 18 and 19
Number of subjects: 7

Group type: COMPARATOR
Intervention: TCR Vbeta 6, 13‐2 and 14
Number of subjects: 7
Study: 8732136

Group type: EXPERIMENTAL
Intervention: Fetal blood transfusion, Chinese medicinal herbs, and Vitamin C
Number of subjects: 43

Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 43
Study: 2745320

Group type: EXPERIMENTAL
Intervention: Endurance training (40 min at 50-70% VO2max for first 13 weeks, 75-85% VO2max for last 13 weeks)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Resistance training (one set of 8-12 repetitions on 10 Nautilus machines, 3 sessions per week for 26 weeks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 47
Study: 886702

Group type: EXPERIMENTAL
Intervention: Preventive therapy for the 'intermediate' group (350 persons)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Surveillance of 10% of the 'normal' group
Number of subjects: 350

Group type: COMPARATOR
Intervention: Surveillance of the whole 'pathological' group
Number of subjects: 350
Study: 31451420

Group type: EXPERIMENTAL
Intervention: Inactivated varicella zoster virus vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 28771262

Group type: EXPERIMENTAL
Intervention: GF rice and corn pasta
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional wheat pasta
Number of subjects: 13
Study: 26595853

Group type: EXPERIMENTAL
Intervention: Intermittent bolus feeding (BOL)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Semicontinuous feeding (CON)
Number of subjects: 246
Study: 23547959

Group type: EXPERIMENTAL
Intervention: Clinical year students
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Female students
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Neck region
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Lower back region
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Students with minimum participation in ergonomics workshops
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Students unfamiliar with treatment and remedies for WMSD
Number of subjects: 568
Study: 21467701

Group type: EXPERIMENTAL
Intervention: Efavirenz with fixed-dose lamivudine and abacavir
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted atazanavir with fixed-dose lamivudine and abacavir
Number of subjects: 71

Group type: COMPARATOR
Intervention: Both arms
Number of subjects: 71
Study: 19628136

Group type: EXPERIMENTAL
Intervention: Project ALERT (school-based drug prevention program)
Number of subjects: 1901

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1901
Study: 16614789

Group type: EXPERIMENTAL
Intervention: Patients with Alzheimer's disease
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study: 15493522

Group type: EXPERIMENTAL
Intervention: ThermaCare HeatWrap
Number of subjects: 0

Group type: COMPARATOR
Intervention: Johnson & Johnson Back Plaster
Number of subjects: 0

Group type: COMPARATOR
Intervention: ABC Warme‐Pflaster
Number of subjects: 0
Study: 11516867

Group type: EXPERIMENTAL
Intervention: LDR-ISRT (70 Gy/4-9 days)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: HDR-ISRT (60 Gy/10 fractions/1 week)
Number of subjects: 51
Study: 9433587

Group type: EXPERIMENTAL
Intervention: Multipoint identity-by-descent method (MIM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-region MIM with sets of six adjacent markers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-region MIM analysis
Number of subjects: 0
Study: 8485791

Group type: EXPERIMENTAL
Intervention: Left lateral decubitus position (n = 22)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sitting position (n = 18)
Number of subjects: 40
Study: 3804564

Group type: EXPERIMENTAL
Intervention: Ephedrine/methylxanthine mixture (22 mg ephedrine, 30 mg caffeine, 50 mg theophylline)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ephedrine/methylxanthine mixture
Number of subjects: 0
Study: 29570595

Group type: EXPERIMENTAL
Intervention: Cluster Training (CT) - 6 sets of 3 × 2 repetitions with 30 seconds rest every 2 repetitions and 4 minutes 30 seconds between sets
Number of subjects: 19

Group type: COMPARATOR
Intervention: Traditional Training (TT) - 6 sets of 6 continuous repetitions with 5 minutes rest between sets
Number of subjects: 19
Study: 27973936

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 20
Study: 25072937

Group type: EXPERIMENTAL
Intervention: Nω‐hydroxy‐nor‐L‐arginine (0.1 mg/min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 24
Study: 22594233

Group type: EXPERIMENTAL
Intervention: Diode laser irradiation after root canal therapy and conservative periodontal treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Root canal therapy and conservative periodontal treatment (scaling and root planning)
Number of subjects: 30
Study: 15759529

Group type: EXPERIMENTAL
Intervention: Isokinetic muscle stretch (20-min session)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Isotonic muscle stretch (20-min session)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 66
Study: 12218231

Group type: EXPERIMENTAL
Intervention: 0.05% RAL
Number of subjects: 22

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 22
Study: 9856368

Group type: EXPERIMENTAL
Intervention: verapamil (240 mg once a day)
Number of subjects: 498

Group type: COMPARATOR
Intervention: chlorthalidone (25 mg once a day)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 498

Group type: COMPARATOR
Intervention: chlorthalidone
Number of subjects: 498
Study: 7874947

Group type: EXPERIMENTAL
Intervention: Guaifenesin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2133226

Group type: EXPERIMENTAL
Intervention: Pentoxifylline therapy
Number of subjects: 0
Study: 484632

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 29137968

Group type: EXPERIMENTAL
Intervention: Displayed bundles of healthy foods with a price discount
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Displayed bundles of healthy foods without a price discount
Number of subjects: 0

Group type: COMPARATOR
Intervention: No bundles displayed (control condition)
Number of subjects: 0
Study: 29098262

Group type: EXPERIMENTAL
Intervention: Rapid prototyping technology
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 120
Study: 25495719

Group type: EXPERIMENTAL
Intervention: Doxazosin 4 mg daily for 12 weeks
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Tolterodine 4 mg daily for 12 weeks
Number of subjects: 163
Study: 24197772

Group type: EXPERIMENTAL
Intervention: Dietary calcium intake and 25 hydroxy vitamin D status
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: High bone turnover
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Calcium intake
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Correlates of high bone turnover
Number of subjects: 305
Study: 20082737

Group type: EXPERIMENTAL
Intervention: High-flavanol cocoa beverage (701 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low-flavanol cocoa beverage (22 mg)
Number of subjects: 21
Study: 19057628

Group type: EXPERIMENTAL
Intervention: Caudal epidural injections with local anesthetic (lidocaine 0.5%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Caudal epidural injections with 0.5% lidocaine mixed with 1 mL of 6 mg non‐particulate Celestone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Caudal epidural injections (both groups)
Number of subjects: 40
Study: 17000387

Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair (LAP)
Number of subjects: 1395

Group type: COMPARATOR
Intervention: Open hernia repair (OPEN)
Number of subjects: 1395
Study: 15030113

Group type: EXPERIMENTAL
Intervention: Individual decision-making
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Non-compensatory decision strategies
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Reception of decision-threatening information
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Single task-oriented group members
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Groups with a task-oriented leader
Number of subjects: 55
Study: 10897159

Group type: EXPERIMENTAL
Intervention: LEV 1,000 mg
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: LEV 3,000 mg
Number of subjects: 246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study: 8604240

Group type: EXPERIMENTAL
Intervention: 6 cycles of the combination of cyclophosphamide (500 mg/m2), mitoxantrone (10 mg/m2), and fluorouracil (500 mg/m2; CNF)
Number of subjects: 362

Group type: COMPARATOR
Intervention: 6 cycles of conventional CMF
Number of subjects: 362